An E Box Comprises a Positional Sensor for Regional Differences in Skeletal Muscle Gene Expression and Methylation  by Ceccarelli, Elena et al.
CM
U
9
Developmental Biology 213, 217–229 (1999)
Article ID dbio.1999.9345, available online at http://www.idealibrary.com onAn E Box Comprises a Positional Sensor for
Regional Differences in Skeletal Muscle
Gene Expression and Methylation
Elena Ceccarelli,1 Michael J. McGrew,2 Tom Nguyen,3 Uta Grieshammer,4
David Horgan, Stephen H. Hughes,* and Nadia Rosenthal5
Cardiovascular Research Center, Massachusetts General Hospital—East, Charlestown,
Massachusetts 02129; and *National Cancer Institute—Frederick Cancer Research Program,
ABL-Basic Research Program, Frederick, Maryland 21702–1013
To dissect the molecular mechanisms conferring positional information in skeletal muscles, we characterized the control
elements responsible for the positionally restricted expression patterns of a muscle-specific transgene reporter, driven by
regulatory sequences from the MLC1/3 locus. These sequences have previously been shown to generate graded transgene
expression in the segmented axial muscles and their myotomal precursors, fortuitously marking their positional address. An
evolutionarily conserved E box in the MLC enhancer core, not recognized by MyoD, is a target for a nuclear protein complex,
present in a variety of tissues, which includes Hox proteins and Zbu1, a DNA-binding member of the SW12/SNF2 gene
family. Mutation of this E box in the MLC enhancer has only a modest positive effect on linked CAT gene expression in
transfected muscle cells, but when introduced into transgenic mice the same mutation elevates CAT transgene expression
in skeletal muscles, specifically releasing the rostral restriction on MLC-CAT transgene expression in the segmented axial
musculature. Increased transgene activity resulting from the E box mutation in the MLC enhancer correlates with reduced
DNA methylation of the distal transgenic MLC1 promoter as well as in the enhancer itself. These results identify an E box
and the proteins that bind to it as a positional sensor responsible for regional differences in axial skeletal muscle gene
expression and accessibility. © 1999 Academic Press
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1INTRODUCTION
Significant progress has been made over the past few
years in defining the molecular circuitry that gives rise to
skeletal muscle lineages in vertebrate embryos. Identifica-
tion of transcription factors controlling the tissue- and
stage-specific expression of the myogenic phenotype has led
to the elucidation of regulatory pathways underlying the
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Yvette France.
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All rights of reproduction in any form reserved.eneration of skeletal muscles from their mesodermal pre-
ursors during development.
Less is understood about the mechanisms responsible for
onferring positional identity on individual muscle groups
ithin the developing embryo and retaining these differ-
nces in the adult musculature. The complex and reproduc-
ble patterns of contractile tissues formed in the embryo,
nd maintained in the adult, are likely to be specified by
ommon pathways patterning functionally related tissues,
uch as nerves, tendon, and bone.
We have previously described a transgenic model that
esponds to positional cues in developing skeletal muscles
long the mouse anteroposterior axis and maintains posi-
ionally restricted patterns of expression in adult muscula-
ure (Donoghue et al., 1991; Grieshammer et al., 1992).
xpression of a variety of transgene reporters, driven by a
200-bp MLC1 promoter and a 920-bp downstream en-
ancer from the MLC1/3 locus, is graded in the developing
omites and retains a rostrocaudal gradient of expression in
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218 Ceccarelli et al.the mature segmented axial muscle derivatives, highest in
posterior muscles (Donoghue et al., 1992a; Grieshammer et
al., 1992, 1993). This unique expression pattern is reflected
in the relative methylation of the transgenic MLC regula-
tory sequences (Donoghue et al., 1992b; Grieshammer et
l., 1995). Endogenous MLC1 gene expression and methyl-
tion are not graded in axial muscles (Grieshammer et al.,
995), suggesting that the MLC sequences isolated in the
ransgenic construct include a DNA module that, when
eparated from its natural genomic milieu, responds to
egional regulators in muscles along the anteroposterior
xis.
To characterize the genetic components of this unusual
xpression pattern, we sought to locate the cis-acting ele-
ents in the MLC regulatory sequences responsible for the
FIG. 1. (A) Sequence comparison of the MLC core enhancer from h
are the MyoD binding sites A, B, and C and the MEF-2 binding s
element (BMW), are also shown in boldface. (B) A homologous BM
sequences.radient in MLC transgene expression. Previous analysis of
he MLC enhancer has identified three E boxes, pairs of
t
t
Copyright © 1999 by Academic Press. All righthich represent functional targets for myogenic factor
inding and enhancer activation (Wentworth et al., 1991)
but do not appear to contribute to the gradient in MLC
transgene expression (Rao et al., 1996). In considering other
andidate sequences, our attention was drawn to an up-
tream region of the MLC enhancer, containing a fourth E
ox (CATGTG), adjoining an A/T-rich motif that includes
wo consensus binding sites for Hox proteins (ATTA).
equences in this region of the MLC enhancer are perfectly
onserved for more than 30 bp between rat, mouse, and
uman (Fig. 1A) (Rosenthal et al., 1990), suggesting that
hey may play an important function in MLC1/3 regulation.
roteins binding to this region include selected Hox pro-
eins (Houghton and Rosenthal, 1999) as well as Zbu1, a
ovel DNA-binding member of the SWI2/SNF2 family of
n, rat, and mouse. Muscle-specific regulatory elements (in boldface)
/T-rich region. A putative Hox protein binding site and an E box
lement is found in the kappa light chain enhancer and promoteruma
ite Aranscriptional cofactors involved in chromatin configura-
ion (Gong et al., 1997). The Hox binding sites in the MLC
s of reproduction in any form reserved.
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219E Box as Positional Sensorenhancer seemed a particularly appealing candidate, since
Hox proteins are involved in the establishment of posi-
tional identity in other somitically derived tissues, such as
the axial skeleton, and have been implicated in the regula-
tion of muscle patterning in both vertebrate and inverte-
brate embryos (reviewed in Olson and Rosenthal, 1994).
Surprisingly, mutation of the Hox sites in the transgenic
MLC enhancer did not lead to changes in the graded pattern
of transgene expression (Rao et al., 1996), suggesting that
other elements in the MLC transgene must be responsive to
regional differences in developing axial muscles.
In this report we demonstrate that the upstream E box
(termed BMW) adjoining the Hox binding sites in the MLC
enhancer acts as a weak negative regulatory element in
muscle cell lines. It does not bind MyoD, but instead is
recognized by a nuclear complex present in a variety of cell
types. In transgenic mice, mutation of the BMW box alone
is sufficient to increase transgene expression in a variety of
muscle groups. The BMW mutation also releases the repres-
sion of an otherwise unmodified MLC transgene in anterior
axial muscles, significantly diminishing the gradient both
in activity and in methylation of the MLC transgenic
sequences in axial musculature. These data implicate an E
box in the MLC enhancer, and the protein complex that
binds to it, as a positional sensor in the establishment of
regionally restricted muscle gene expression and accessibil-
ity along the anteroposterior axis.
MATERIAL AND METHODS
Plasmids and site-directed mutagenesis. The MSV-MyoD ex-
pression vector (Davis et al., 1987) was a gift from A. Lassar and H.
eintraub. Plasmid MLC1CATBMW (abbreviated BMW in figures)
as generated by polymerase chain reaction (PCR) mutagenesis
Libri et al., 1995) of pMLC1CAT920 (Rosenthal et al., 1989)
abbreviated WT in figures). The BMW site was mutated at the
ame residues shown by the methylation interference experiments
o be important for the binding of the BMW protein complex
pBMW), using the following oligonucleotides:
BMWmut 59-TGAGCGGTTCACACTACCTAATTTAA-
TAAGGTTAGGTCC-39
59MLC 59-CGCGGATCCGCTATTAATCCC-39
39MLC 59-CGCGGATCCGAGCTTTAAGATAC-39
he mutagenic oligonucleotide (BMWmut), the 59MLC oligonucle-
tide, and 100 ng of the wild-type template (pMLC1CAT920) were
sed to obtain a primary PCR product. A second PCR was per-
ormed using as primers the primary PCR product and the oligo-
ucleotide 39MLC. The resulting PCR product was then cloned in
he BamHI sites of the reporter plasmid pMLC1CAT. Vent poly-
erase was used to minimize PCR error and the entire mutant
LC enhancer was double-strand sequenced.
Transgenic mice. A 3.7-kb AccI fragment was excised frompMLC1CATBMW expression cassettes (see Fig. 2) and injected into
pronuclei of fertilized mouse eggs as described by Hogan et al.
f
d
Copyright © 1999 by Academic Press. All right(1986). Potential founders were screened for transgene integration
by tail blotting with 32P-labeled CAT DNA probe (Rosenthal et al.,
1989). The three founder lines (BMW Nos. 3, 4, and 9) expressing
the transgene were established by mating positive animals to
(C57BL6 3 CBA) F1 mice. F1 progenies were checked for the
resence of the transgene by PCR amplification of tail genomic
NA with primers specific for the CAT gene. Transgene copy
umber was determined by Southern blot (30–50 copies in BMW 3
nd 4, ,5 copies in BMW 9) and by comparison to transgenic mice
arrying 40 copies of the wild-type MLC genomic fragment (line 7;
rieshammer et al.). Line 7 was chosen as a representative wild-
ype MLC-CAT line because it had a transgene copy number
omparable to that of the BMW mutant lines, and because it
xpressed the MLC-CAT transgene at levels similar to those
easured in multiple independently derived MLC-CAT lines (see
osenthal et al., 1989).
Cell culture, DNA transfection, and CAT assays. NIH3T3
ouse fibroblasts were propagated in Dulbecco’s modified Eagle
edium (DMEM) containing 10% fetal calf serum (FCS), 2%
lutamine, and 50 units/ml penicillin–streptomycin, and seeded for
ransfection at 1 3 106 cells/100-mm plate. The C2C12 mouse
keletal muscle cell line (Blau et al., 1985) was cultured in DMEM
upplemented with 20% FCS and seeded for transfections on
00-mm plates at 1 3 105 cells for myoblasts and 4 3 105 cells for
myotubes. Plasmids were transfected into NIH3T3 and C2C12
cells by calcium phosphate coprecipitation (Graham et al., 1975)
using 10 mg of reporter construct, 5 mg of MSV-myoD expression
vector, and 2 mg of a SV40-luciferase control plasmid. The medium
as changed after 16 h (DMEM containing 10% FCS for NIH3T3
ells, 20% FCS for myoblasts, and 2% horse serum for myotubes).
orty-eight hours later, cells were harvested according to published
rotocols (Rosenthal, 1987). Luciferase enzymatic assays were
arried out to normalize the amount of cell extract used for CAT
ssays. CAT enzymatic assays were performed according to Seed
nd Sheen (1988). For CAT assays on transgenic mice, mouse
issues were dissected and frozen in dry ice, and protein extract was
repared by successive cycles of freeze/thawing. CAT assays were
etermined on adult heterozygotes (5 weeks or older). Three mice
rom each founder line were analyzed. The amount of extract used
or the CAT assays was normalized to total protein content. CAT
ssays were performed as described by Gorman et al. (1982). In Fig.
, each experimental set was normalized to the EDL muscle (set to
00). MLC line 7 Absolute values for each muscle varied less than
03 between the four lines, with line 9 being the weakest expres-
or. Relative values of absolute CAT activity for the four lines
Nos. 3, 4, 7, 9) in masseter (a weakly expressing muscle) and EDL
a strongly expressing muscle), expressed as fold difference in
bsolute CAT activity, setting No. 7 masseter at 1, were as follows:
,3,7,1 for masseter; 28, 45, 42, 11 for EDL.
Detection of genomic methylation. Preparation of genomic
NA and quantitative analysis of transgene methylation were
erformed essentially as described (Grieshammer et al., 1995),
sing a ligation-mediated PCR procedure (McGrew and Rosenthal,
993), with PCR programs shortened to 30 s for denaturation, 45 s
or annealing, and 30 s for extension. Analyses were performed on
ultiple DNA samples prepared from at least three different
nimals in each line, and were repeated at least twice for each
ample.
Electrophoresis mobility shift assay (EMSA) and methylation
nterference footprinting. Binding and reaction conditions used
or EMSAs and methylation interference footprinting have been
escribed in Wentworth et al. (1991). Approximately 400 ng of
s of reproduction in any form reserved.
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221E Box as Positional Sensorpurified fusion protein (GST-MyoD) or 10 mg of nuclear extract was
used for EMSAs in a reaction volume of 20 ml containing 10 mM
epes (pH 7.9), 50 mM NaCl, and 1 mg of poly(d(I–C)). Nuclear
xtracts from HeLa, C2C12, and NIH3T3 cell lines were prepared
y the method of Dignam et al. (1983). Jurkat, 70Z, and 70Z cells
reated with lipopolisaccharide (LPS) nuclear extracts were a gen-
rous gift of J. Sharon. Total protein concentration was determined
pectrophotometrically using a standard Bradford assay. To gener-
te larger probes for EMSAs, fragments of the 173-bp MLC en-
ancer (see Fig. 5A, wt173 and mABC) were 32P end-labeled on the
sense or antisense strand of the vector pCAT173 at the polylinker
restriction sites (Wentworth et al., 1991). The following comple-
mentary oligonucleotides were synthesized:
BMW 20-mer 59-TCGACAAATTACCATGTGTG-39
BMW 59-GGACCTAACCTTATTAAATTACCATG-
TGTGAACCGCTCA-39
mBMW 59-GGACCTAACCTTATTAAATTAGGTAG-
TGTGAACCGCTCA-39
A 59-GTCGCAGCAGGTGCA-39
C 59-CGAAGCAACAGGTGCCT-39
AT 59-TTTTAAAAATAACTTTT-39
For EMSAs, the oligonucleotides listed above were annealed and
end-labeled with 32P using the Klenow fragment (Promega). In
ompetition experiments, double-stranded annealed oligonucleo-
ides were used at a 100-fold molar excess unless indicated other-
ise in the figure legends. For the methylation interference foot-
rinting, the antisense fragment of the 173-bp MLC enhancer
mABC) was 32P end-labeled as described in Wentworth et al.
(1991).
RESULTS
An E Box in the MLC Enhancer Acts
as a Negative Element
The MLC enhancer core presents a high degree of con-
servation between mouse, rat, and human over a region
that has been previously shown to be important for muscle-
specific expression both in tissue culture (Rosenthal, 1989;
Rosenthal et al., 1990; Wentworth et al., 1991) and in
transgenic mice (Rosenthal et al., 1989). Multiple con-
served regions in the MLC enhancer core constitute targets
for specific myogenic factors (Fig. 1A) including members
of the MyoD (sites A, B, and C) and MEF2 (A/T rich site)
FIG. 2. (A) Structure of the WT and BMW MLC-CAT expression
mice. (B) MLC-CAT activity in nonmuscle (top) and muscle (bo
transgenes. In NIH3T3 cells, MLC enhancer activity was tested by trans
each bar is the average of at least three experiments (with standard erro
Copyright © 1999 by Academic Press. All rightamilies. In addition, a pair of consensus Hox protein
inding sites (CTTATTAAATTA) (Rao et al., 1996) and an
djacent E box (CATGTG), termed BMW, also show a high
egree of conservation (Fig. 1A), suggesting a possible func-
ion in MLC enhancer activity.
To investigate whether the BMW box was involved in
nhancer-mediated transcriptional activation, an MLC en-
ancer variant in which the BMW motif was altered by
ligonucleotide-directed mutagenesis (Fig. 2A) was tested
or its ability to drive transcription from an otherwise
nmodified MLC1 promoter-CAT expression cassette in
ransient transfections of C2C12 muscle and NIH3T3 fibro-
last cell lines. In NIH3T3 cells, muscle-specific activity of
oth wild-type (WT) and mutant (BMW) MLC enhancers
as tested by transactivation with a cotransfected MyoD
xpression vector. As previously shown (Wentworth et al.,
991), MyoD efficiently transactivated wild-type MLC
nhancer-driven CAT gene expression. The BMW-mutated
nhancer responded to MyoD transactivation as strongly as
id the wild-type enhancer in NIH3T3 fibroblasts (Fig. 2B,
op). In C2C12 differentiated myotubes, however, the BMW
utation resulted in a twofold increase in CAT activity
ver that driven by a WT enhancer (Fig. 2B, bottom). Thus,
nlike other E boxes in the MLC enhancer, the BMW box is
ot a functional site for transactivation by MyoD and
ppears to have a repressive role on the muscle-specific
ction of the MLC enhancer.
Mutation of the BMW Box Releases the Gradient of
MLC-CAT Transgene Expression in Axial Muscles
To assess the function of the BMW box in vivo, where it
might affect temporal or spatial activation of linked re-
porter gene activity, transgenic mice were generated with
the MLC-CAT construct carrying the BMW mutation in the
downstream enhancer. Five germline-integrated founder
lines were established, and CAT transgene activity was
determined in protein extracts of muscle and liver tissue
from representative animals of the five lines. Two lines did
not express the transgene in either tissue. The other three
lines (BMW 3, 4, and 9) all expressed high levels of trans-
gene expression and were analyzed for CAT activity in
muscle and nonmuscle tissue. As shown in Fig. 3A, mice
carrying an MLC-CAT cassette driven by the wild-type
MLC enhancer expressed the transgene in a complex pat-
tern. As previously described (Donoghue et al., 1991; Grie-
hammer et al., 1992), transgene expression was low in the
asseter and diaphragm and graded in the intercostal
uscles, with very low expression levels in liver, lung,
pleen, stomach, and heart. In comparison, mice carrying an
ette used in transfection experiments and to generate transgenic
) cells transfected with wild-type and BMW-mutated MLC-CATcass
ttomactivation with a cotransfected MyoD expression vector. Value for
r).
s of reproduction in any form reserved.
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223E Box as Positional SensorMLC-CAT cassette driven by the BMW mutant enhancer
retained muscle-specific transgene expression, but at a
consistently higher level, specifically in the masseter and
diaphragm. Moreover, the BMW mutation largely alleviated
CAT transgene repression in the rostral intercostal
muscles, which expressed 10- to 15-fold higher levels of
transgene activity compared with the wild-type transgene
(average values from all BMW lines is shown in Fig. 3B).
Thus the BMW box acts as a repressor of MLC transgene
expression, most notably in anterior axial muscle groups.
Positionally Restricted Methylation of Transgenic
MLC Regulatory Sequences Is Relieved by
Mutation of the BMW E Box
Multiple lines of evidence from this and other laborato-
ries (Donoghue et al., 1992b; Grieshammer et al., 1995)
ave shown that positional differences in MLC-CAT trans-
ene expression, both in intact muscles and in primary
ransgenic muscle cell cultures, cannot be attributed to
ifferences in transcriptional competence, but rather reflect
he extent of CpG methylation in both MLC1 promoter and
LC enhancer sequences. Taken together, these studies
mplicate selective methylation in the maintenance of
ifferent gene expression patterns in skeletal muscles, and
stablish the downstream enhancer of the MLC1/3 locus as
target for epigenetic modification.
To determine whether increases in MLC-CAT transgene
xpression elicited by mutation of the BMW E box corre-
ated with changes in the methylation status of transgene
equences, we examined methylation of selected CpG resi-
ues in the transgenic MLC1 promoter and MLC enhancer,
y a quantitative PCR-based analysis (Grieshammer et al.,
995; McGrew and Rosenthal, 1993) of DNA from the
uscles of wild-type and BMW mutant lines. As seen in
ig. 4, mutation of the BMW E box released the rostrocaudal
radient of MLC enhancer methylation in intercostal
uscles, and resulted in demethylation of the enhancer in
elected muscles such as the diaphragm. Unexpectedly, the
ffect of the BMW mutation was more pronounced on the
ransgenic MLC1 promoter, which was significantly less
ethylated in rostral intercostal muscles, as well as in the
iaphragm and masseter. The changes in methylation of
pGs in the proximal enhancer and distal promoter result-
ng from the BMW mutation correlated well with corre-
ponding changes in expression of the MLC-CAT transgene
Fig. 3), supporting a role for methylation in the mainte-
FIG. 3. Wild-type and BMW MLC-CAT transgene expression in ad
from various adult tissues (IC, intercostal muscle; EDL, extenso
MLC-CAT transgenic lines (BMW Nos. 3, 4, 9) and a wild-type MLC
in the rostral intercostal muscle of three independent BMW-muta
Values (with standard error) from three to six independent experime
(set to 100). Note the log scale of relative CAT activity. The shading den
the figure). The relative position of the muscle is indicated at the botto
Copyright © 1999 by Academic Press. All rightance of positional differences in MLC-CAT transgene
ranscription.
The BMW Box Is Recognized by a Nuclear Protein
Complex but Not by MyoD
The results described above implicate the BMW E box,
and the proteins that bind to it, in the rostrocaudal gradient
of MLC-CAT transgene expression. Bacterially expressed
GST–MyoD fusion protein binds specifically to other E
boxes (A, B, and C) in the enhancer (Wentworth et al., 1991),
although MyoD-containing complexes derived from cell
extracts do not recognize the B box (Rosenthal et al., 1990),
resumably because it does not represent an optimal bind-
ng site for MyoD–E protein heterodimers (Huang et al.,
1996). The A, B, and C motifs appear to be the only bona
fide MyoD binding sites in the enhancer, since a 173-bp
enhancer fragment in which all three sites were mu-
tagenized did not form a complex with GST–MyoD (Fig. 5A,
lane 2). As seen in Fig. 5B (lane 1), the GST–MyoD fusion
protein did not bind a 20-bp oligonucleotide probe contain-
ing the BMW site. Thus, the upstream BMW box is not a
target for MyoD in vitro.
Since previous DNase protection analysis of the MLC
enhancer with a HeLa cell extract revealed a footprint over the
BMW site (B. M. Wentworth and N.R., unpublished observa-
tions) gel shift assays with nuclear extracts from HeLa cells
were performed to identify nuclear protein complexes that
interact with this sequence. As seen in Fig. 5B, a protein–DNA
complex was observed with HeLanuclear extracts using the
BMW site as probe (lane 4). The specificity of this interaction
was confirmed by competition experiments with a 100-fold
molar excess of unlabeled BMW oligonucleotide or an unre-
lated AT-rich oligonucleotide constituting the MEF2 site in
the MLC enhancer (Fig. 5B, lanes 5 and 6). To further demon-
strate the binding specificity of the HeLa protein complex
with the BMW site, competition experiments were carried out
using an excess of unlabeled oligonucleotides constituting the
E boxes in BMW, A or C sites (Fig. 5C, lanes 2–4). Only the
BMW E box was able to compete the binding of the HeLa
nuclear extract, while the E boxes in sites A and C could not.
The same sequence specificity of complex binding was ob-
served in gel shift assays using C2C12 nuclear extracts (data
not shown and see below). These results demonstrate that the
BMW E box in the MLC enhancer is recognized specifically by
a ubiquitous nuclear protein complex, termed pBMW, that is
different from that formed over sites A and C.
keletal muscle. (A) CAT assays were performed on protein extracts
italis longus) isolated from three independently generated BMW
T transgenic line (No. 7) (Grieshammer et al., 1992). (B) Expression
LC-CAT transgenic lines compared with wild type (WT, No. 7).
ere averaged and normalized to the expression of CAT in the EDLult s
r dig
-CA
ted M
nts wsity reflects the relative difference in CAT activity (see bottom of
m: R, rostral; C, caudal.
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224 Ceccarelli et al.Mapping pBMW Binding Sites within
the BMW Box
The specific nucleotides in the MLC enhancer to which
pBMW binds were mapped by methylation interference assays
on an MLC enhancer fragment carrying mutations in sites A,
B, and C. Comparison of the methylation pattern seen on
the protein-bound DNA sample (Fig. 6A, lane B) with that
on free DNA (Fig. 6A, lane F) established positions of
protein–DNA interaction. As shown in Fig. 6A, pBMW
contacted two G residues on the antisense strand at the
BMW box. To further define the bases necessary for pBMW
binding, we generated a mutated oligonucleotide of 40 bp
(mBMW) containing the adjoining Hox and BMW sites in
the MLC enhancer. Mutations were introduced in the two
FIG. 4. Methylation of promoter and enhancer sequences in wild-
the MLC enhancer (HhaI site) and in the MLC1 promoter (ThaI sit
(IC, intercostal muscle; EDL, extensor digitalis longus) in wild-ty
Percentage demethylation was calculated as previously described (
products analyzed by gel electrophoresis and autoradiography. Val
were averaged. The gray shading reflects the relative levels of deme
indicated at the bottom: R, rostral; C, caudal.G residues shown to be important for the binding of pBMW
by methylation interference, and in two adjacent bases of
Copyright © 1999 by Academic Press. All righthe E box element. EMSAs were carried out using a 40-bp
ild-type BMW probe and either wild type or the mBMW
ligonucleotide. As shown in Fig. 6B, the BMW complex in
2C12 nuclear extracts was not competed by the unlabeled
BMW oligonucleotide, even at 300-fold molar excess (Fig.
B, lane 7), while a 50-fold molar excess of unlabeled BMW
ligonucleotide was sufficient to compete for the binding of
his complex (Fig. 6B, lane 2). This analysis confirms that
ontact nucleotides identified by footprinting analysis of
he BMW box are essential for pBMW binding.
The BMW Protein Complex Is Abundant in
Undifferentiated Cell Types
A variety of cell lines were screened for the presence of the
(WT) and BMW-mutated MLC-CAT transgenes. Demethylation in
alyzed by LMPCR. Genomic DNA was isolated from adult tissues
LC-CAT and multiple BMW MLC-CAT lines described in Fig. 3.
hammer et al., 1995) from densitometric scans of labeled LMPCR
with standard error) from at least three independent experiments
tion in each muscle group. The relative position of the muscles istype
e) an
pe M
Gries
ues (pBMW complex by gel shift assays, using the BMW box as
probe. As shown in Fig. 7A, nuclear extracts from HeLa cells,
s of reproduction in any form reserved.
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225E Box as Positional SensorNIH 3T3 fibroblasts, C2C12 myoblasts, and myotubes and
Jurkat cells (a T-lymphocyte line) formed a protein complex of
the same mobility as pBMW, whereas L6 cells, 10T1/2, and
foreskin fibroblasts (FS4) did not (data not shown). The rela-
tively low level of protein binding in extracts from C2C12
myotubes relative to C2C12 myoblasts (compare lanes 4 and
3 in Fig. 7A) suggests that pBMW might be more abundant in
undifferentiated cells, consistent with the negative regulatory
activity of the BMW box in differentiated myocytes. Similarly,
extracts from undifferentiated 70Z pre-B cells formed a
sequence-specific complex with the BMW probe (Fig. 7B, lanes
1–4), while the same complex was absent in nuclear extract
from 70Z cells differentiated into mature B cells by LPS
treatment (Fig. 7B, lane 5). Taken together, these results
suggest a general inhibitory function for the pBMW complex
in regulating differentiation-specific gene expression.
DISCUSSION
The BMW E Box Is a Positional Sensor
FIG. 5. (A) MLC enhancer fragments 32P-labeled wild type (wt173,
ombined with GST–MyoD bacterial fusion protein and analyzed
lanes 1–3) or nuclear extracts from HeLa cells (lanes 4–6) were incu
Competition experiments were performed with 100-fold molar e
oligonucleotide (lanes 3 and 6). (C) Nuclear extracts from HeLa
experiments were carried out using 100-fold molar excess of unlabe
the A box (lane 3) or the C box (lane 4).The discovery that transgenic reporters driven by reg-
ulatory elements from the MLC1/3 locus faithfully mark
f
s
Copyright © 1999 by Academic Press. All righthe positional address in segmented axial muscles by
raded expression along the AP axis (Donoghue et al.,
991; Grieshammer et al., 1992) provided an experimen-
al model to investigate the molecular basis of regional
dentity in these tissues. This avenue of investigation has
ow led to the identification of a single cis-acting ele-
ent in the MLC enhancer that responds to regional
egulators in the segmented axial muscles. Mutation of
he BMW E box in this element releases the rostral re-
triction of linked transgene expression and alters the
ethylation of both proximal and distal regulatory se-
uences in the transgene.
Molecular studies of axial specification in inverte-
rates have indicated that skeletal muscles within indi-
idual body segments are specified by common pathways
nvolved in establishing segmental identity in other cell
ypes. The establishment of the embryonic body plan is
ontrolled at least in part by the homeodomain gene
amily, which regulates downstream gene expression pro-
rams in spatially and temporally restricted patterns to
pecify the body axes. Although a cell-autonomous role
1) or mutated at the three MyoD binding sites (mABC, lane 2) were
lectrophoretic mobility shift assay. (B) GST–MyoD fusion protein
with a 32P-labeled 20-bp oligonucleotide containing the BMW site.
of unlabeled BMW oligonucleotide (lanes 2 and 5) or A/T-rich
s were incubated with the 20-bp BMW probe and competition
MW oligonucleotide (lane 2) or oligonucleotides containing eitherlane
by e
bated
xcess
cellor homeobox genes in the positional identity of Dro-
ophila muscles has been demonstrated (Michelson,
s of reproduction in any form reserved.
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positional specificity on segmented muscles in verte-
brates has been elusive, partly because it is more difficult
to score morphological differences in muscles associated
with different vertebral segments than in the segmented
musculature of flies (reviewed in Olson and Rosenthal,
1994). By identifying a positional sensor in vertebrate
muscle capable of modulating the accessibility of both
proximal and distal regulatory DNA sequences to the
transcriptional apparatus, this study provides a molecu-
FIG. 6. (A) Methylation interference footprinting of HeLa nu-
lear extract bound to the MLC enhancer mutated at sites A, B,
nd C. The mABC enhancer fragment was labeled on the anti-
ense strand and binding to nuclear extracts was assayed by
ethylation interference on bound (lane B) and free (lane F)
NA. The footprint pattern is shown as well as the BMW site
underline) near the F lane. (B) Nuclear extracts from C2C12
ells were incubated with a 32P-labeled 40-bp oligonucleotide
ontaining the HOX and BMW conserved regions of the MLC
nhancer core. Competition experiments were performed with
0 (lane 2)-, 100 (lane 3)-, and 200 (lane 4)-fold molar excess of
nlabeled 40-mer BMW oligonucleotide or with 100 (lane 5)-,
00 (lane 6)-, and 300 (lane 7)-fold molar excess of unlabeled
BMW mutant oligonucleotide.lar model of regional regulation in skeletal muscle whose
mechanistic details can now be further dissected.
Copyright © 1999 by Academic Press. All rightRole of Myogenic Factors in MLC-CAT
Transgene Expression
The characterization of proteins binding to the BMW box
suggests that it is not responsive to the MyoD family of
bHLH myogenic factors. Pathways distinct from those
responsible for the myogenic phenotype may therefore by
responsible for conferring positional identity on the mam-
malian axial musculature. Gene knockout phenotypes in-
dicate that at least some of these factors, such as myogenin,
are critical for establishment of differentiation-specific gene
expression programs, while others, such as myf5, specify
skeletal muscle lineages in the early embryo (Arnold and
Braun, 1996). None of the myogenic bHLH factors charac-
terized to date are likely to confer positional information in
the embryo, although they are clearly involved in establish-
ing muscle cell-specific patterns of gene expression, operat-
ing through other E boxes in the MLC enhancer. It is
therefore not surprising that a DNA regulatory element
that participates in positional sensing during embryonic
development should interact with factors other than those
belonging to the MyoD family.
The pBMW Complex and Repression
of Gene Activity
The pBMW nuclear protein complex defined in this study
is potentially responsible for establishing positional infor-
mation through its interaction with an E box, a sequence
motif more commonly present in muscle control elements
as a target for myogenic bHLH factors. The possibility
remains that one of the unknown proteins in the pBMW
complex is actually a bHLH factor acting in concert with
other factors, such as Zbu1 and Hox proteins, which are
known to bind the BMW element (Gong et al., 1997; Rao et
al., 1996). The BMW sequence (CATGTG) diverges from
the optimal sequence for myogenic factors, binding as
heterodimers with E proteins (CAGGTG), although the
CANNTG core of the BMW box is identical to that of the
MCK enhancer Left-E box, which is similarly adjacent to an
A/T-rich site. In contrast to the BMW box, mutations of the
Left-E box lead to decreased expression in skeletal muscle
cells (Amacher et al., 1993). Notably, multimerized MCK
Left-E boxes are more active in NIH3T3 cells and in
myoblasts than multimerized MCK Right-E boxes which
contain the higher-affinity MyoD binding site (Apone and
Hauschka, 1995).
Other sites to which the BMW box bears resemblence lie
in the regulatory elements of B-lymphocyte-specific genes.
A search of the kappa light chain locus for sequences
sharing homology to the BMW box revealed conserved
BMW-like motifs present in the kappa light chain promoter
(Boyd et al., 1986) and enhancer elements (Picard and
Schaffner, 1984) (Fig. 1B). The pBMW complex is present in
the pre-B cell line 70Z, but absent from 70Z cells treated
with LPS (see Fig. 7), which elicits cellular responses
leading to the expression of B-cell-specific genes such as the
kappa light chain immunoglobulin. It is therefore possible
s of reproduction in any form reserved.
b
w
n 100
o (lane
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targets for the pBMW complex, which may participate in
their repression, in either undifferentiated cells or, postmi-
totically, in nonpermissive tissue types.
Although the identity of each protein in the pBMW
complex has yet to be determined, previous studies indicate
that proteins from the Hox class of regulatory factors bind
directly to the BMW site and/or the adjoining AT-rich
motifs (Rao et al., 1996; Gong et al., 1997). These proteins
might be acting directly to specify positionally restricted
expression patterns on structural genes, as suggested by the
requirement for one of these proteins, Hoxc-8, in maximal
MLC-CAT transgene expression in selected muscles
(Houghton and Rosenthal, 1999). This would be an unor-
thodox role for clustered Hox genes, which have been
considered master regulators of the vertebrate body plan.
Hox gene products are unexpectedly abundant in neonatal
and adult muscle, however (Houghton and Rosenthal,
1999), and it remains to be seen whether they play a
secondary role in regulating structural genes in these tis-
FIG. 7. (A) Mobility shift assays were performed with nuclear ext
(lane 3), myotubes (lane 4), and Jurkat cells (lane 5). 32P-labeled 20-m
y gel electrophoresis. (B) Nuclear extracts from the pre-B 70Z cells
ere incubated with the 20-bp BMW probe (lanes 1 and 5, respect
uclear extracts, competition experiments were carried out using
ligonucleotides containing either the A box (lane 3) or the C boxsues during development or later in regeneration, perhaps
through interaction with intermediary factors that control
Copyright © 1999 by Academic Press. All rightgene accessibility. Another protein previously character-
ized by its affinity for the BMW site is Zbu1 (Gong et al.,
1997), a novel DNA-binding member of the SWI2/SNF2
family of transcription cofactors which have been impli-
cated in a number of DNA transactions such as chromatin
remodeling and transcription (Tsukiyama and Wu, 1997).
Originally isolated using the BMW box as a DNA target,
Zbu1 may have a more restricted DNA specificity in the
context of the pBMW complex. The uniformly high accu-
mulation of Zbu1 protein in postmitotic tissues such as
skeletal muscle, heart, and brain (S. Kaushal and N. R.
unpublished results) and the increased MLC-CAT trans-
gene expression resulting from mutation of its target BMW
box in the MLC enhancer (Fig. 3) suggest that Zbu1 may be
collaborating with other factors in the pBMW complex to
specify regional differences in gene accessibility in differen-
tiated tissues. Since Zbu1 itself is expressed relatively late
in embryonic development, and its transcripts are not
graded in axial muscles, it might play an ancillary role,
possibly through chromatin remodeling, to establish posi-
from HeLa cells (lane 1), NIH3T3 cells (lane 2), C2C12 myoblasts
MW oligonucleotide was combined with the extracts and analyzed
mature B 70Z cells [after treatment with lipopolysaccharide (LPS)]
), and to assess the specificity of the complex formed by the 70Z
-fold molar excess of unlabeled BMW oligonucleotide (lane 2) or
4).racts
er B
and
ivelytional information in concert with other proteins that are
themselves differentially distributed.
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228 Ceccarelli et al.Control of MLC1 Promoter Methylation by a Distal
Regulatory Element
The most dramatic effect of the BMW mutation on
MLC-CAT transgene methylation is on the MLC1 pro-
moter, which would be situated several thousand bases
away from the MLC enhancer in either direction among
tandem arrays of MLC-CAT transcription units. The ability
of the BMW box to effect such distal changes in epigenetic
DNA modification is similar to the action of other known
methylation regulators, specifically the one between the
H19 and IGF2 genes (Bartolomei and Tilghman, 1997;
Surani, 1998; Webber et al., 1998), where a short sequence
element has been identified as a regulator of parental
imprinting through selective methylation (Birger et al.,
1999). In the endogenous MLC1/3 locus, control of MLC1
promoter activity by methylation appears to be site specific,
since the internal MLC3 promoter is ubiquitously demeth-
ylated (McGrew et al., 1996). In contrast, control of MLC1
promoter activity by methylation is tissue specific, since
nonmuscle tissues, such as the heart, do not exhibit any
changes in the highly methylated state of MLC-CAT trans-
gene sequences carrying the BMW mutation (Fig. 4).
Although the relative chromatin configuration of trans-
genic wild-type and mutant MLC sequences has yet to be
analyzed, a general cause-and-effect relationship between
DNA methylation and the regulation of gene accessibility
has been suggested by the interaction of the methyl CpG-
binding protein MeCP2 and histone deacetylase activity,
leading to acetylation of histones and transcriptionally
repressive chromatin (Eden et al., 1998; Jones et al., 1998;
an et al., 1998). Recent demonstration of the synergy
etween demethylation and histone deacetylase inhibition
n the reactivation of gene expression in cancer (Cameron et
l., 1999) establishes a dynamic interaction between the
wo processes, and further demonstrates the dominance of
NA methylation in the stable maintenance of gene repres-
ion. Extrapolating these concepts to differentiation-
pecific gene regulation would suggest that the release of
LC-CAT transgene repression in selected skeletal
uscles by mutation of the BMW box is causally related to
he demethylation of promoter and enhancer sequences
een in the transgene.
Specification of Muscle Positional Identity by Gene
Accessibility
What is the function of the BMW box in the endogenous
MLC1/3 locus, where other regulatory sites with similar
protein binding capacities may exist? Although the steady-
state levels of transcripts from the endogenous MLC1/3
locus are not graded, increased activity of the BMW-
mutated MLC enhancer in muscle cell transfections sug-
gests a repressive role. The variable effect of the BMW
mutation on MLC-CAT transgene activity in different
muscle groups in vivo argues for a more complex role in
maintaining regional distinctions of structural gene expres-
sion. Variations in gene accessibility could be achieved
Copyright © 1999 by Academic Press. All righthrough the recognition of regulatory elements such as the
MW box by specific DNA-binding protein complexes,
ollowed by local DNA methylation which may lock genes
nto a silenced chromatin configuration (Cameron et al.,
999). Thus the fortuitous phenomenon of graded MLC-
AT transgene expression provides a model for the molecu-
ar analysis of regional gene regulation. Although endoge-
ous muscle-specific genes regulated in this pattern have
et to be identified, it follows that the initial abundance or
omposition of the pBMW complex in different tissues may
etermine the relative accessibility of specific genes to
ranscriptional activation, perhaps through controlling
ethylation patterns. From a survey of cell types where the
BMW complex is present it appears that the complex may
e active while cells are still in a proliferative state. The
dentification of a molecular target for positional restriction
f transcriptional activity through epigenetic mechanisms
hould hasten progress in elucidating general processes
nderlying regional regulation of tissue-specific genes.
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